SEC Company Response from LEHMAN BROTHERS HOLDINGS INC (CIK 0000806085) — Dec 5, 2005
LEHMAN BROTHERS HOLDINGS INC (CIK 0000806085)
Date: Dec. 5, 2005 · CIK: 0000806085 · Accession: 0000893750-05-000576
AI Filing Summary & Sentiment
File numbers found in text: 001-09466
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
LEHMAN BROTHERS
December 5, 2005
Mr. Amit Pande
Assistant Chief Accountant
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Lehman Brothers Holdings Inc.
Commission File No. 001-09466
Form 10-K for the Fiscal Year Ended November 30, 2004
Forms 10-Q for the Quarters Ended February 28, 2005, May 31, 2005 and
August 31, 2005
Dear Mr. Pande:
The following responses are provided in connection with your November 18, 2005
letter (the "Comment Letter") regarding the Securities and Exchange Commission
("SEC" or "Commission") staff's review of Lehman Brothers Holdings Inc.'s
(together with its subsidiaries, the "Company," "we," or "our") Annual Report on
Form 10-K for the year ended November 30, 2004 and Forms 10-Q for the quarterly
periods ended February 28, 2005, May 31, 2005 and August 31, 2005 (together the
"Filings"). Included below are the Company's responses to the questions raised
in the Comment Letter. Numbered paragraphs below correspond to the numbered
paragraphs in the Comment Letter. In responding to the Comment Letter we
acknowledge that:
o The Company is responsible for the adequacy and accuracy of the disclosure
in the Filings;
o Staff comments or changes to disclosure in response to staff comments do
not foreclose the Commission from taking any action with respect to the
Filings; and
o The Company may not assert staff comments as a defense in any proceeding
initiated by the Commission or any person under the federal securities laws
of the United States.
<PAGE>
Mr. Amit Pande Page 2
Securities and Exchange Commission
Form 10-K for the Fiscal Year Ended November 30, 2004
Consolidated Financial Statements
Notes to Consolidated Financial Statements
Note 1. Summary of Significant Accounting Policies - Consolidation Accounting
Policies
1. We note that you adopted FASB Interpretation No. 46R (FIN 46R) for all
variable interest entities (VIEs) in which you hold a variable interest in
2004. Please revise your future filings to include all disclosures required
by paragraphs 23-26 of FIN 46R related to VIEs in which you are either the
primary beneficiary or hold a significant variable interest, or tell us why
these disclosures are not required.
FIN 46R paragraphs 23-26 require disclosures associated with consolidated
and unconsolidated variable interest entities (VIEs). In Note 4
Securitizations and Other Off-Balance-Sheet Arrangements we provide FIN 46R
disclosures associated with our involvement with consolidated and
unconsolidated VIEs, under the heading Non-QSPE Activities.
In future filings, we will provide a cross-reference in Note 1 to these
additional disclosures in Note 4, and we will also expand our disclosures
of consolidated VIEs in accordance with FIN 46R paragraphs 23-26 to include
the amount and the balance sheet classification of the underlying VIE
assets as well as the amount of non-recourse financing.
Note 6. Business Combinations
2. We note that the Neuberger final purchase price adjustment of $307 million
recorded in 2004 was based on a third-party valuation of restricted common
shares issued in the business combination. We further note that these
shares were initially valued at a 25% discount to market value based on a
third-party valuation. Please tell us the discount to market you applied to
determine the revised value of these shares and how you determined that the
revised value represented the fair value of issued shares.
In Note 7 Identifiable Intangible Assets and Goodwill we disclose that
during 2004 we finalized the purchase price valuation of the Neuberger
acquisition and, as a result, we reduced the initial purchase price
valuation by approximately $307 million. The $307 million adjustment to the
initial purchase price valuation is the dollar value equivalent of the 25%
discount to market value for the restricted shares issued in the
acquisition (as discussed in Note 6). The initial purchase price valuation
did not utilize a discount to the market value for these restricted shares.
The 25% discount to the market value for the restricted shares reflects
selling restrictions that extend through 2011, and is based on an
independent third-party valuation.
<PAGE>
Mr. Amit Pande Page 3
Securities and Exchange Commission
Note 7. Identifiable Intangible Assets and Goodwill
3. Please describe the nature of your mutual fund customer-related intangibles
and tell us how you determined that they are indefinite lived, indicating
the authoritative guidance upon which you rely including your consideration
of paragraph 11 of SFAS 142.
SFAS 142 paragraph 11 requires recognition of intangible assets to be based
on their useful lives to the reporting entity. If no legal, regulatory,
contractual, competitive, economic, or other factors limit the useful life
of an intangible asset, the useful life should be considered to be
indefinite. In addition, the reporting entity should consider whether any
legal, regulatory, or contractual provisions that enable renewal or
extension of the assets legal or contractual life can be accomplished
without substantial cost.
In analyzing the useful life of the purchased mutual fund customer-related
intangibles, we considered the nature of the investment management
agreements and the historical experience of the Neuberger Berman branded
mutual funds. Neuberger Berman has investment management agreements
directly with the mutual funds rather than with investors in the mutual
funds. The decision to extend the investment management agreements with
Neuberger Berman branded funds is made by the independent Board of
Directors for the respective mutual funds. Historical experience has shown
that Neuberger Berman has always been re-appointed as the asset manager for
every Neuberger Berman branded mutual fund. The Neuberger Berman branded
funds have been in existence for 23 years on average, with lifespans
ranging from 2 to 55 years. Given management's expectation of perpetual
renewal of the investment management agreements with the Neuberger Berman
branded funds at little to no cost, mutual fund customer-related
intangibles were deemed to have an indefinite life.
The Company performs an annual impairment review for all intangible assets,
including indefinite life intangibles in accordance with SFAS 142.
Note 10. Fair Value of Financial Instruments
4. Please revise future filings to present the fair value of your financial
instruments, including off balance-sheet financial instruments, with the
related carrying amount in a form that makes it clear whether the fair
value and carrying amount represent assets or liabilities and how the
carrying amounts relate to what is reported in the statement of financial
position. Refer to Paragraph 10 of SFAS 107, as amended by paragraph 532 of
SFAS 133.
In Note 10 Fair Value of Financial Instruments we disclose that all
on-balance-sheet financial instruments (assets and liabilities) are
recorded at fair value or amounts that approximate fair value, other than
long-term debt liabilities and certain long-term repurchase agreements, for
which we disclose our carrying value and related fair value as of November
30, 2004.
In future filings, we will revise our disclosures to state that our
off-balance-sheet financial instruments are also carried at fair value,
including all derivatives, guarantees and lending-related commitments. In
addition, we will, as requested, also more clearly present the fair value
and carrying value of each financial asset and liability not carried at
fair value or at an amount that approximates fair value.
<PAGE>
Mr. Amit Pande Page 4
Securities and Exchange Commission
Note 11. Commitments and Contingencies
5. We note your disclosures about the settlement amounts related to two
litigation matters. Please tell us and revise future filings to
o Quantify for each year presented the amounts accrued in connection with
litigation matters for which you believe it is probable that a liability
was incurred or an asset impaired; and
o Quantify the range of possible loss for those matters where you believe
that there is at least a reasonable possibility that a loss or an
additional loss that may have been incurred.
If you do not have probable losses or losses which are reasonably possible,
please state so in future filings. Please refer to SFAS 5 and FIN 14.
The Company records loss accruals for litigation matters meeting the SFAS 5
criteria of a probable loss and for which the loss amount, or minimum
amount, can be reasonably estimated. The Company discloses the nature of
all significant litigation matters under Item 3, Legal Proceedings in the
Form 10-K. We have provided the amount of the Company's liability for
litigation matters as of November 30, 2004 to you supplementally. The
Company has not disclosed the dollar amount of liabilities recognized for
litigation matters because the amount is not considered to be material to
the Company's financial condition. SFAS 5 states that the amount of an
accrual recognized in accordance with SFAS 5 may be necessary to be
disclosed in some circumstances for the financial statements not to be
misleading. After giving consideration to the litigation matters
outstanding in the periods presented and our estimate of probable losses
and the reasonably possible range of losses, we do not believe further
disclosure of such matters is necessary for the financial statements not to
be misleading.
6. Please tell us and revise future filings to disclose how the $280 million
settlement with your insurance carriers for the litigation occurring prior
to January 2003 and the $223 million settlement under the Memorandum of
Understanding for the Enron litigation did not result in a net gain or
loss.
The $280 million settlement with our insurance carriers related to several
matters, including Enron, Worldcom and other matters. There was no net gain
or loss on this settlement with our insurance carriers, as the $280 million
represented the aggregate settlement associated with all these matters.
In future filings, we will include this clarification as the reason why the
settlement did not result in a net gain or loss.
<PAGE>
Mr. Amit Pande Page 5
Securities and Exchange Commission
Note 16. Incentive Plans - Restricted Stock Units
7. We note that in 2004 you measured compensation cost for your restricted
stock units (RSUs) based on the market value of your common stock at the
date of grant less a discount for sale restriction. We further note that a
discount was not applied to awards granted prior to 2004. Please tell us
and revise future filings to disclose the reasons for the accounting
change.
We disclosed in Note 1 Summary of Significant Accounting Policies (under
the subcaption Equity-Based Compensation) that the Company adopted the SFAS
123 fair-value method of accounting for equity-based employee awards
beginning in 2004. In accordance with SFAS 123, RSU awards were recorded at
fair value. Fair value included recognition of a discount from the market
value of our unrestricted common stock on the date of grant, to reflect
selling restrictions subsequent to the vesting date of the RSU. The Company
elected to utilize the prospective transition method permitted by SFAS 148,
"Accounting for Stock-Based Compensation - Transition and Disclosure."
Under this method of transition, equity-based employee awards for the years
ended November 30, 2003 and before continue to be accounted for under APB
25, utilizing the intrinsic value method of recognizing compensation
expense. Therefore, discounts associated with selling restrictions after
the vesting date were not recognized for awards granted prior to 2004.
In future filings we will clarify in Note 16 that the adoption of SFAS 123
was the reason for this change in measurement.
8. Please tell us the impact of applying this sale restriction discount in
2004 on your RSU compensation cost.
Beginning in 2004, RSU awards were recorded at fair value which included
recognition of a discount from the market value of our unrestricted common
stock on the date of grant to reflect selling restrictions after the
vesting date of the RSU. We have provided the effect of utilizing a selling
restriction discount on our 2004 compensation expense to you
supplementally.
<PAGE>
Mr. Amit Pande Page 6
Securities and Exchange Commission
9. In the first paragraph on page 117 you state that you included 39.9 million
amortized RSUs in your basic and diluted earnings per share at November 30,
2004. We note in the table on page 116 that you had a total of 64.24
million RSUs outstanding at November 30, 2004. Please clarify why the
number of RSUs included in your diluted earnings per share calculations on
page 114 is only 2.2 million when compared to the remaining 24.34 million
unamortized RSUs.
Of the 24.3 million remaining unamortized RSUs noted, 10.5 million were
granted on the last day of fiscal 2004 and, therefore, had only a nominal
impact on diluted earnings per share. The remaining 13.8 million
unamortized RSUs resulted in 2.2 million shares being utilized in the
computation of diluted earnings per share, in accordance with the treasury
stock method. In applying the treasury stock method, the unamortized
compensation cost and the hypothetical tax benefit were deemed to be
proceeds used to repurchase common stock and, therefore, offset the
potential dilutive effect of the remaining unamortized RSUs.
Please feel free to call me at (212) 526-9295 if you wish to discuss any of our
responses to the Comment Letter, or to answer any other questions you may have.
Sincerely,
/s/ Christopher M. O'Meara
--------------------------
Christopher M. O'Meara
Chief Financial Officer
Lehman Brothers Holdings Inc.
</TEXT>
</DOCUMENT>